Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 2020

View Archived Issues

Carbon dioxide and the brain

Researchers report identification of TQ-05310, a novel potent mutant IDH2 inhibitor

First-in-human data published for the pan-PIM kinase inhibitor PIM-447

Murine CD16.28z CAR iNKT cells exert both direct and indirect antitumor effects in vivo

Preliminary data from phase III ASCERTAIN study of ASTX-727

CohBar discovers novel peptide inhibitors of CXCR4

FDA clears IND for ADXS-504 as treatment of prostate cancer

Positive topline data from phase Ib study of CBP-201 in moderate to severe atopic dermatitis

Topline data from pivotal phase II portion of the ACTION-Galactosemia study

SR-4835, a novel CDK12/13 dual inhibitor for treating triple-negative breast cancer

Abbisko Therapeutics divulges FGFR-1 and/or FGFR-2 inhibitors

New treatment discovered for heart tissue scarring after infarct

Novartis presents new compounds for dengue

FDA clears Carmell's IND for pivotal study of BHA for open tibia fractures

Bone Biologics' rhNELL-1 growth factor promotes bone formation in preclinical study

Merck & Co. identifies new arginase inhibitors

ViiV Healthcare UK describes HIV integrase inhibitors

Eli Lilly and Company patents OGA inhibitors

Scynexis reports new phase III interim data with ibrexafungerp in invasive fungal infections

Blueprint releases topline data for pralsetinib in RET fusion-positive NSCLC

Agenus begins phase I study with bispecific antibody AGEN-1223

DBV reports data from open-label extension study of Viaskin Peanut

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...